The lawsuits began piling in October 2021 — about four months after the recall — according to court documents. Since then, the FDA has reported more than 105,000 injuries and 385 deaths related to the recall.
Philips Respironics filed for a partial settlement agreement, which is subject to the court’s approval, to offer between $50 and $1,500 to each customer, according to The New York Times.
In a news release, the company said the decision is not an admission of liability or guilt.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.